Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.5400 (1.82%) ($7.5400 - $7.5400) on Wed. Jan. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.99% (three month average) | RSI | 34 | Latest Price | $7.5400(1.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.4% a day on average for past five trading days. | Weekly Trend | BCRX declines -5.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(38%) IWO(38%) IWC(37%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.495% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.495% (StdDev 4.99%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.72 | 5 Day Moving Average | $7.46(1.07%) | 10 Day Moving Average | $7.39(2.03%) | 20 Day Moving Average | $7.72(-2.33%) | To recent high | -11.6% | To recent low | 49.8% | Market Cap | $1.33b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |